Description
Sorbilact (sorbitol) Solution for Infusion 400 ml. Vial
Introduction:
Sorbilact is a Solution for Infusion contained in a 400 ml. vial. It is composed of sorbitol, a sugar alcohol commonly used as a sweetener in various food products and also as a medication. Sorbilact is administered intravenously for various medical conditions, as directed by healthcare professionals.
Composition:
The active ingredient in Sorbilact is sorbitol. Sorbitol is a sugar alcohol that is derived from glucose and is commonly used as a sweetening agent in various food products. In the case of Sorbilact, sorbitol is formulated as a Solution for Infusion in a 400 ml. vial.
Indications:
Sorbilact is indicated for use in various medical conditions, including:
- As a diuretic to increase urine production in cases of acute kidney injury or poisoning.
- As an osmotic laxative to relieve constipation.
- As a source of carbohydrate and calorie for patients who are unable to take food orally.
- As a component of total parenteral nutrition (TPN) in hospitalized patients.
Administration:
Sorbilact is administered intravenously by healthcare professionals in a clinical setting. The dosage and rate of infusion will be determined by the healthcare provider based on the patient’s condition and needs. It is essential to follow the healthcare provider’s instructions carefully when administering Sorbilact.
Contraindications:
Sorbilact should not be used in patients with known hypersensitivity to sorbitol or any of the components of the solution. It should also be used with caution in patients with diabetes, as sorbitol can affect blood sugar levels.
Side Effects:
Like any medication, Sorbilact may cause side effects in some patients. Common side effects may include:
- Diarrhea
- Abdominal discomfort
- Nausea
- Flatulence
If any of these side effects persist or worsen, it is important to inform the healthcare provider promptly.
Precautions:
Prior to administering Sorbilact, healthcare providers should consider the following precautions:
- Monitor blood sugar levels in diabetic patients receiving Sorbilact.
- Ensure adequate hydration during and after administration of Sorbilact.
- Monitor for signs of fluid overload, especially in patients with compromised cardiac function.
- Use with caution in patients with renal impairment.
Storage:
Sorbilact should be stored at room temperature away from direct sunlight and heat sources. It should be kept out of reach of children and pets. Do not freeze the solution, and discard any unused portion after single-use.
Conclusion:
Sorbilact is a Solution for Infusion containing sorbitol, used for various medical indications such as diuresis, osmotic laxation, and as a source of carbohydrate and calorie. It is administered intravenously under the supervision of healthcare professionals. Patients should follow the instructions provided by their healthcare provider and report any side effects or concerns promptly.
